Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Self-Assembling Aromatic Peptide Amphiphile Fibers for Multivalent Display of Enzymatically Linked Antigenic Proteins.

ACS applied materials & interfaces·2025

Same author

Peptide Materials.

Biomacromolecules·2025

Same author

Drug-Inspired Design of Supramolecular Polymers for Enhanced Drug Loading and Sustained Therapeutic Release.

ACS nano·2025

Same author

Effective communication with JCR editors in the peer review process.

Journal of controlled release : official journal of the Controlled Release Society·2025

Same author

Balancing Chemical and Supramolecular Stability in OEGylated Supramolecular Polymers for Systemic Drug Delivery.

Journal of the American Chemical Society·2025

Same author

Self-Assembling Peptides, Conjugates, and Mimics: A Versatile Platform for Materials and Beyond.

Accounts of chemical research·2025

Same journal

Cardiomyocyte-derived USP20 mitigates myocardial ischemia/reperfusion injury through deubiquitinating GRP78.

Theranostics·2026

Same journal

Ion-Responsive Microneedles Delivering Subtype-Specific Mitochondrial Extracellular Vesicles from HEY1⁺ Cardiomyocytes for Cardiac Repair in Bama Minipigs with Myocardial Ischemia-Reperfusion Injury.

Theranostics·2026

Same journal

Mechano-immune interactions in musculoskeletal aging: Mechanisms and translational perspectives.

Theranostics·2026

Same journal

Peripheral blood immune profiling reveals key signatures in newly diagnosed NK/T cell lymphoma patients.

Theranostics·2026

Same journal

Sonogenetics for precision medicine: from molecular toolkit to clinical translation.

Theranostics·2026

Same journal

Programmable pH-responsive DNA inter-strand matching (PRISM) for precision molecular band-pass actuation.

Theranostics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 18, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Nanostructure-Based Theranostic Systems.

Jun Wang¹, Honggang Cui²

¹1. Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Technology of China, Hefei Anhui 230027, PR China; 2. CAS Center for Excellence in Nanoscience, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei Anhui 230027, PR China; 3. Innovation Center for Cell Signaling Network, University of Science and Technology of China, Hefei, Anhui 230027, PR China.

|July 5, 2016

Summary

This summary is machine-generated.

This issue explores advanced nanoscaled theranostic systems for early cancer diagnosis and effective treatment. These innovations aim to improve disease management through precise detection and targeted therapies.

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Mar 18, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

Area of Science:

Nanotechnology and its application in medicine.
Theranostic systems for disease management.

Background:

Focus on recent developments in nanoscaled theranostic systems.
Application in early and accurate disease diagnosis, particularly for cancer.

Discussion:

Integration of diagnostic and therapeutic capabilities at the nanoscale.
Addressing challenges in cancer diagnosis and treatment.

Key Insights:

Nanoscaled systems offer enhanced precision for early cancer detection.
Theranostic approaches improve treatment efficacy and patient management.

Outlook:

Future potential of theranostic nanotechnology in oncology.
Advancements in personalized cancer care through nanomedicine.